5,221 Shares in The Allstate Co. (NYSE:ALL) Bought by Aigen Investment Management LP

Aigen Investment Management LP purchased a new position in The Allstate Co. (NYSE:ALL) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 5,221 shares of the insurance provider’s stock, valued at approximately $990,000.

A number of other hedge funds also recently modified their holdings of the stock. BDF Gestion purchased a new stake in shares of Allstate during the second quarter worth about $3,051,000. OFI Invest Asset Management bought a new stake in shares of Allstate in the second quarter worth approximately $476,000. Cetera Investment Advisers raised its stake in Allstate by 351.6% during the 1st quarter. Cetera Investment Advisers now owns 65,221 shares of the insurance provider’s stock valued at $11,284,000 after buying an additional 50,780 shares during the last quarter. Diversified Trust Co lifted its holdings in Allstate by 505.3% in the second quarter. Diversified Trust Co now owns 7,923 shares of the insurance provider’s stock valued at $1,265,000 after acquiring an additional 6,614 shares during the period. Finally, Canada Pension Plan Investment Board boosted its holdings in shares of Allstate by 97.5% in the first quarter. Canada Pension Plan Investment Board now owns 271,464 shares of the insurance provider’s stock worth $46,966,000 after buying an additional 134,028 shares during the last quarter. Institutional investors own 76.47% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently weighed in on ALL shares. Evercore ISI upped their target price on shares of Allstate from $191.00 to $195.00 and gave the stock an “in-line” rating in a report on Wednesday, October 9th. Bank of America boosted their target price on shares of Allstate from $216.00 to $233.00 and gave the stock a “buy” rating in a report on Friday, October 18th. Keefe, Bruyette & Woods lifted their price target on Allstate from $222.00 to $225.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 6th. BMO Capital Markets upped their price objective on Allstate from $205.00 to $214.00 and gave the company an “outperform” rating in a research report on Friday, October 18th. Finally, JPMorgan Chase & Co. boosted their target price on Allstate from $205.00 to $207.00 and gave the company an “overweight” rating in a research report on Thursday, October 10th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $212.56.

Insider Buying and Selling

In other Allstate news, CEO Thomas J. Wilson sold 90,000 shares of Allstate stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total value of $16,140,600.00. Following the sale, the chief executive officer now owns 88,552 shares in the company, valued at $15,880,915.68. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other Allstate news, EVP Elizabeth Brady sold 49,481 shares of Allstate stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $179.09, for a total transaction of $8,861,552.29. Following the transaction, the executive vice president now owns 19,163 shares of the company’s stock, valued at $3,431,901.67. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Thomas J. Wilson sold 90,000 shares of the firm’s stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total transaction of $16,140,600.00. Following the transaction, the chief executive officer now directly owns 88,552 shares in the company, valued at $15,880,915.68. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 192,530 shares of company stock worth $34,967,665. Insiders own 1.80% of the company’s stock.

Allstate Price Performance

Shares of ALL opened at $198.03 on Wednesday. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.40 and a current ratio of 0.40. The stock has a market capitalization of $52.44 billion, a PE ratio of 12.83, a PEG ratio of 1.83 and a beta of 0.48. The company has a 50 day moving average price of $189.26 and a 200-day moving average price of $176.05. The Allstate Co. has a fifty-two week low of $129.17 and a fifty-two week high of $201.00.

Allstate (NYSE:ALL) last announced its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, beating the consensus estimate of $2.20 by $1.71. The firm had revenue of $16.63 billion during the quarter, compared to analyst estimates of $14.57 billion. Allstate had a net margin of 6.77% and a return on equity of 26.67%. Allstate’s revenue was up 14.7% on a year-over-year basis. During the same period last year, the firm posted $0.81 EPS. Equities analysts predict that The Allstate Co. will post 15.32 earnings per share for the current fiscal year.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.